NURECA

www.nureca.com Dated-21.07.2026 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA Corporate Relations Department LIMITED Phiroze Jeejeebhoy Towers Listing Department Dalal Street, Fort Exchange Plaza, 5th Floor, Plot no. C/1 Mumbai-400001 G Block, Bandra Kurla Complex, Bandra (E) Scrip code: 543264 Mumbai-400051 Scrip Code: NURECA Subject: Investor Presentation (Q1&FY’27) Dear Sir/ Madam, In furtherance to the un-audited standalone and consolidated financial results of the Company already forwarded to the stock exchanges this day in compliance of Regulations 30, 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, also please find enclosed herewith Investor Presentation (Q1&FY’27) based on the financial performance of the Company for the quarter ended June 30, 2026. The above is for your information and records. Thanking you, Yours faithfully, For Nureca Limited (Nishu Kansal) Company Secretary & Compliance Officer M. No. A33372 NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 Investor Presentation Q1 & FY’27 Trusted for Life Building India’s leading consumer healthcare platform across brands, connected devices, omnichannel distribution and manufacturing. Disclaimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any investor should subscribe / purchase the company shares. The Company makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information contained herein. This presentation may include certain “forward looking statements”. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from these statements. Important factors that could cause actual results to differ materially from our expectations include, amongst others, general economic and business conditions in India and abroad, ability to successfully implement our strategy, our research & development efforts, our growth & expansion plans and technological changes, changes in the Indian and international interest rates, change in laws and regulations that apply to the healthcare industry, increasing competition, changes in political conditions in India. Neither the company, nor its Directors and any of the affiliates or employee have any obligation to update or otherwise revise any forward-looking statements. The readers may use their own judgment and are advised to make their own calculations before deciding on any matter based on the information given herein. No part of this presentation may be reproduced, quoted or circulated without prior written approval from Nureca Ltd. Table of Contents 1 The Quarter at a Glance 2 Financial Performance 3 About our Business 4 Growth & Outlook Dear Shareholders, The operational turnaround we delivered in FY26 has carried into the new financial year. Our focus remains on profitable growth and disciplined cost management as we build out our consumer healthcare platform across healthcare, wellness and personal-care categories. Manufacturing will be central to our long-term strategy. The expansion of our capabilities in Punjab is intended to deepen supply-chain control and import substitution, while opening new opportunities in medical devices, healthcare consumables and hygiene products. Alongside this, Dr Trust 360 continues to strengthen our connected-health ecosystem, now with AI-powered health insights for our users. I thank our shareholders, employees, channel partners and customers for their continued trust. We remain committed to building a stronger, more efficient and innovation-led organisation that creates sustainable value for all stakeholders. Saurabh Goyal Chairman & Managing Director SECTION 1 · QUARTER AT A GLANCE Q1 FY'27 Highlights ₹ 40.3 Cr ₹ 51.8 Cr 38.8 % Revenue from Operations GMV Gross Margin ▲ 14% QoQ (Q4 FY 26: ₹35.4 Cr) · 18% YoY Q4 FY 26: ₹ 49.7 Cr 6 bps YoY ₹ 3.4 Cr ( 8.7% ) ₹ 4.43 Cr ( 10.5% ) ₹ 110 Cr Operating Profit / Margin Profit Before Tax Net Cash & Investments vs ₹2.5 Cr (7.2%) in Q4 FY 26 Reported PAT: ₹ 3.1 Cr Debt-free Your Company achieved its highest quarterly sales & Profitability in last 16 quarters, marking its strongest performance since Q4 FY 2021–22. Operating Profit → PBT Bridge (Q1 FY'27 Actuals) + ₹ 1.82 Cr − ₹ 0.20 Cr − ₹ 0.61 Cr ₹ 4.43 Cr Q1 FY'27 ₹ 3.42 Cr PBT ₹ 4.43 Cr 10.5% of revenue Operating Profit PBT Other Income Finance Cost Depreciation (8.5% of revenue) (10.1% of revenue) P&L Summary (Consolidated) ₹ Crore Q1' FY 27 Q4' FY 26 QoQ % Q1' FY 26 YoY % Revenue from operations 40.3 35.4 14% 34.2 18% Other Income 1.8 1.0 80% 2.6 -31% Total Revenue 42.1 36.4 16% 36.8 14% Total Expenses 36.9 41.1 -10% 34.8 6% Operating Profits 3.5 2.6 35% -0.6 683% EBITDA 5.2 -4.7 211% 2.0 160% Finance Cost 0.2 0.3 -33% 0.2 0% Depreciation 0.6 0.4 50% 0.5 20% PBT 4.4 -5.4 181% 1.3 238% Current tax 0.2 1.8 -89% 0.1 100% Deferred tax 1.1 -1.2 192% 0.3 267% PAT 3.1 -6.0 152% 0.9 244% Total Comprehensive Income 3.1 -5.9 153% 0.9 244% EPS (in INR) 3.2 -6.45 150% 0.8 300% Gross Margin% 39% 40% -1% 35% 4% Operating Margin% 8.7% 7.3% 1.3% -1.8% 10.4% EBITDA% 12% -13% 25% 5% 7% PAT% 7.4% -16.5% 23.8% 2.4% 4.9% Nureca at a Glance A branded consumer healthcare platform Combining products, distribution, digital health and manufacturing Connected health Trusted consumer brands Omnichannel distribution Manufacturing-led growth ecosystem B D 360 M Expanding domestic Online marketplaces, quick Dr Trust and Dr Physio Dr Trust 360 linking smart production in medical commerce, across home healthcare and devices, health data and devices, healthcare direct-to-consumer and wellness personalised insights consumables and hygiene offline trade products From digital-first healthcare products to an integrated consumer healthcare platform Brand Range Role Key Product Categories Example Products Vital monitoring, chronic care devices, connected Dr Trust Point of Care Monitoring and diagnosis at home BP monitors, glucometers, pulse oximeters, thermometers, nebulizers health devices Everyday fitness, body tracking, and Body metrics, activity support, exercise and fitness Personal scales, body composition scales, smart scales, yoga and exercise accessories, fitness Dr Trust Fitness active wellness tools tracking products Massage-led pain relief, muscle Massage guns, foot massagers, neck massagers, back massagers, handheld and portable Dr Physio Massage Therapy relaxation, and recovery support massagers Dr Trust Therapy & Heat therapy, pain management, Heat therapy, rehab devices, recovery tools, pain Heating pads, hot water bags, TENS/EMS devices, rehab and mobility support devices Recovery rehabilitation, and recovery support management devices Passive support, posture, and comfort Bracing, support, ergonomic comfort, orthopedic Lumbar supports, knee supports, posture correctors, coccyx cushions, cervical pillows, Dr Trust Orthotics solutions aids orthopedic cushions, memory foam pillows Care, comfort, and wellness solutions Mother care, baby care, feeding support, baby Breast pumps, bottle sterilizers, baby thermometers, nasal aspirators, baby grooming kits, Trumom Mother & Baby for mothers and infants monitoring and comfort feeding and comfort products Wellness-oriented home environment Air care, kitchen wellness, home wellness Dr Trust Healthy Home Air purifiers, humidifiers, steamers, kitchen scales, home wellness devices and home utility products appliances Revenue by Channel Trajectory Commentary • Ecommerce: Online Sales increased by 16% (YoY) & 5% (QoQ) results with category expansion and sustainability under existing categories • Offline Retail Network: revenue trend increased to 57% (YoY) & 14% (QoQ) coverage expands with super stockists and new distributors Current Manufacturing base: quality, agility and control NTPL provides the operating foundation for a manufacturing-led growth 8 Lakh 15 Units annual capacity CDSCO approvals Existing Indian manufacturing capacity Quality clearances Categories manufactured at NTPL Mohali • BP monitors, nebulizers, thermometers and massagers • Heating pads, orthopaedic cushions and supports • Breast pumps, vaporizers, stethoscopes and soft orthopaedic goods Revenue from in house manufacturing products FY 26 26% Q1 FY 27 27% ISO 9001:2015 TUV India | ISO 13485:2016 TUV India | USFDA Registration No. 3036779619 | USFDA 510(k) exempt approval for 16 products 15 Connected Health: Dr Trust 360 ecosystem Smart Body composition scales, Blood Pressure Monitors, Kitchen Scales 2.4 Million AI App users Health insights Dr Trust 360 user base Trend detection and summaries Dr Trust 360 is Nureca’s connected-health platform, integrating smart devices, health data and AI-powered insights to build a scalable digital ecosystem and deepen customer engagement. Ecosystem logic Smart Devices Data Layer AI Intelligence High Engagement BP, Smart scales, Reports, trends, Personalised Customer satisfaction kitchen scales baselines summaries 11 The Story of Nureca A journey of trust, innovation and impact 2016 2019 2021 2023 2025 • Birth of Nureca Revenue crosses USD 10 Mn — pure • Listed on NSE & BSE • Ranked “India's No.1 Home • USFDA-registration completed for • Dr Trust launched digitally e-commerce sales • Listed in ET Best Healthcare Healthcare & Wellness Brand” Mohali facility Brands • Ranked in “Most Innovative Companies of India” • Dr Trust 360 crosses 1 Mn users 2018 2020 2022 2024 2026 Brand portfolio expands with Dr • Dr Trust 360 connected device • Manufacturing in India begins • Dr Trust gains "Well Known Dr Trust 360 app crosses 2 million Physio & Trumom ecosystem launched • ISO 9001 & ISO 13485 certified Trademark” users and escalates to Top 50 Health • Rohit Sharma signs as brand • Expands into quick commerce & Fitness app on IOS store. ambassador • Expands to 20,000+ pharmacies App launched in Nepal • Pharmexcil recognizes Dr Trust as a offline “household name in India” • Certified ”Great Place to Work” Construction begins for new medical • ET Premium Prestigious Brand device facility at Sundran, Punjab INDUSTRY LANDSCAPE Home Healthcare Products Market — India & Neighboring Countries Market size in ₹ Crore, 2025–2030E CAGR 2025–30E: 9.9% ₹5,203 Reading the Market 5,000 ₹4,727 ₹4,298 1,408 ₹3,911 • ₹3,240 Cr → ₹5,203 Cr by 2030E — a 1.6x 4,000 1,315 ₹3,559 market at 9.9% CAGR 1,228 289 ₹3,240 1,147 253 • Fastest-growing categories: pulse oximeters 3,000 1,071 222 846 (~15%), thermometers (~14%), massagers 1,000 769 (~12%) 195 699 327 171 635 284 • Nureca competes in all eight categories 150 387 2,000 578 247 358 today 525 215 332 250 187 307 229 161 284 210 263 193 177 1,000 163 1,149 1,289 1,024 725 813 913 253 278 306 336 370 407 0 2025 2026 2027 2028 2029 2030 Digital BP Monitors Massagers Weighing & Kitchen Scales Nebulizers Pulse Oximeters Humidifiers & Steamers Digital & Infrared Thermometers Self-Monitoring Glucose Devices Sources: Frost & Sullivan and other industry reports; Statista. Data extrapolated as per company estimates. Thank You THINK. FEEL. CREATE. Investor Relations: Nishu Kansal · investor@nureca.com Corporate: www.nureca.com · Ecommerce Store: www.drtrust.in Address : Andheri West B-205, Bldg 42, B-Wing, Dhanashree Heights, Azad Nagar Sangam CHS, Andheri West, Mumbai, Maharashtra, India - 400053